IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals & Pharmaceuticals is engaged in the manufacturing and selling of APIs / bulk drugs and speciality chemicals.(Source : 201903 Annual Report Page No: 40)

Pros:
Company has reduced debt.
Company is expected to give good quarter
Company has good consistent profit growth of 135.18% over 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 36.73%
Cons:
Though the company is reporting repeated profits, it is not paying out dividend

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Figures in Rs. Crores

Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019
172 183 193 215 218 263 288 362 423 478 422 493
147 158 167 189 189 231 255 322 348 343 265 348
Operating Profit 25 25 26 26 29 32 32 40 75 136 157 145
OPM % 15% 14% 14% 12% 13% 12% 11% 11% 18% 28% 37% 29%
Other Income 0 0 0 1 1 1 3 4 6 1 2 3
Interest 17 17 17 17 17 16 15 16 14 13 9 8
Depreciation 7 8 7 7 8 8 8 8 8 8 8 9
Profit before tax 1 1 2 3 6 10 13 20 59 115 143 131
Tax % 25% 23% 14% 6% 24% 8% 10% 27% 35% 29% 29% 35%
Net Profit 1 1 2 3 4 9 11 14 38 82 102 85
EPS in Rs 0.17 0.18 0.35 0.53 0.79 1.56 2.05 2.56 6.84 14.63 18.08 15.00
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
316 301 347 387 471 482 564 385 580 711 983 1,685 1,816
280 268 309 319 402 392 468 373 529 608 863 1,276 1,304
Operating Profit 36 33 39 68 69 89 96 11 51 102 120 410 512
OPM % 12% 11% 11% 18% 15% 18% 17% 3% 9% 14% 12% 24% 28%
Other Income 0 3 1 2 2 3 1 1 1 1 6 10 12
Interest 13 15 15 37 43 57 60 59 61 68 64 51 44
Depreciation 7 10 10 24 24 31 32 29 30 30 30 32 33
Profit before tax 16 11 15 9 4 3 5 -75 -39 6 31 336 448
Tax % 24% -14% 32% 32% -25% 46% 35% 12% -4% 21% 12% 30%
Net Profit 12 13 10 6 5 2 3 -67 -40 5 28 237 308
EPS in Rs 9.24 6.99 4.41 2.40 1.85 0.61 1.15 0.00 0.00 0.83 4.93 41.61 54.55
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% -0% -0% 0% 0% 0%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:18.82%
5 Years:24.50%
3 Years:42.66%
TTM:60.76%
Compounded Profit Growth
10 Years:33.98%
5 Years:135.18%
3 Years:99.36%
TTM:686.12%
Return on Equity
10 Years:9.70%
5 Years:14.39%
3 Years:36.73%
Last Year:68.60%

Balance Sheet Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
18 23 28 31 31 31 49 48 56 56 56 57
Reserves 48 79 116 140 142 142 160 154 129 132 160 417
Borrowings 113 247 269 337 394 400 357 400 453 447 422 284
82 93 134 141 175 211 247 160 197 252 287 243
Total Liabilities 256 437 542 644 738 779 793 762 835 888 925 1,002
127 123 373 351 462 430 411 403 400 374 406 412
CWIP 26 187 1 57 12 32 33 4 4 21 7 27
Investments 0 0 0 0 0 0 0 0 0 0 0 0
103 127 169 236 264 318 349 355 431 492 512 563
Total Assets 256 437 542 644 738 779 793 762 835 888 925 1,002

Cash Flows Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
22 16 31 24 55 53 78 -47 18 83 120 273
-47 -167 -67 -69 -87 -18 -12 -5 -27 -23 -50 -63
25 154 35 59 23 -32 -66 50 9 -60 -70 -197
Net Cash Flow 0 3 -0 13 -9 3 1 -2 -0 1 -1 13

Ratios Figures in Rs. Crores

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 19% 10% 8% 10% 9% 11% 11% -3% 4% 12% 15% 56%
Debtor Days 37 31 32 29 17 27 32 31 55 58 54 43
Inventory Turnover 9.72 6.90 5.83 4.65 4.07 3.26 3.17 1.90 2.63 2.90 4.18 8.51